Author: Serretti A. Zanardi R. Cusin C. Rossini D. Lorenzi C. Smeraldi E.
Publisher: Elsevier
ISSN: 0924-977X
Source: European Neuropsychopharmacology, Vol.11, Iss.5, 2001-10, pp. : 375-380
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
CYP1A2 genetic polymorphisms are associated with treatment response to the antidepressant paroxetine
By Lin Keh-Ming Tsou Hsiao-Hui Tsai I-Ju Hsiao Mei-Chun Hsiao Chin-Fu Liu Chia-Yih Shen Winston W Tang Hwa-Sheng Fang Chun-Kai Wu Chi-Shin Lu Shao-Chun Kuo Hsiang-Wei Liu Shu Chih Chan Hsiu-Wen Hsu Ya-Ting Tian Jia-Ni Liu Yu-Li
Pharmacogenomics, Vol. 11, Iss. 11, 2010-11 ,pp. :
Aroclor 1254 inhibits tryptophan hydroxylase activity in rat brain
By Khan Izhar
Archives of Toxicology, Vol. 78, Iss. 6, 2004-06 ,pp. :
By Fleckenstein A.E. Beyeler M.L. Jackson J.C. Wilkins D.G. Gibb J.W. Hanson G.R.
European Journal of Pharmacology, Vol. 324, Iss. 2, 1997-04 ,pp. :